Aelish Marie Baig is a partner in Robbins Geller Rudman & Dowd LLP’s San Francisco office and specializes in consumer and securities fraud actions. Aelish has litigated a number of cases through jury trial, resulting in multi-million and billion dollar awards and settlements for her clients.
Baig was one of the originators of the national opioid litigation, filing among the earliest complaints against the opioid industry defendants and working on all aspects of that litigation. In 2022, Baig served as co-trial counsel in a federal bench trial in San Francisco in a case selected as a bellwether in the national multi-district opioid litigation. The team achieved combined settlements of over $350 million for San Francisco and contributed to securing more than $50 billion for local governments nationwide to be used for abatement of the national opioid epidemic.
Baig was also appointed to leadership in the Juul ($1.7 billion settlement) and McKinsey ($230 million settlement) MDL litigations. She was recently appointed to the Plaintiffs’ Steering Committee of the national social media litigation MDL against the country’s largest social media platforms (Meta, YouTube, Snapchat, and Tiktok) for fueling addiction and other mental health issues among youth. She represents numerous local and state governments and school districts across the country that have filed federal cases against opioids, McKinsey, Juul, and/or social media defendants.
Lawdragon Honors
Baig has also prosecuted securities fraud and derivative actions obtaining millions of dollars in recoveries against corporations such as Wells Fargo, Celera, Pall, and Prudential.
Baig serves as a Board member for Legal Aid at Work, a highly respected non-profit organization committed to enforcing and strengthening the civil and employment rights of low-wage workers in California and across the country. She earned her Bachelor of Arts degree from Brown University and her Juris Doctor degree from American University, where she was senior editor of the Administrative Law Review.